EBIOTECH business Reneuron Group has warned it could enter administration and is preparing to make redundancies as its shares were suspended from trading. The AIM-listed company, which is headquartered in Pencoed, Wales, is in a "highly constrained financial position" and that it requires additional financing "urgently, in order to continue as a going concern". Reneuron Group added that it has found itself in this position after not being able to secure a "validating, revenue-generating industry partnership" or additional equity funding. It said it needs to put staffat risk of redundancy and initiate discussions with its creditors.

(c) 2024 City A.M., source Newspaper